
Sign up to save your podcasts
Or


Plus: The FDA approves a new drug designed to cut the risk of addiction and overdoses related to opioids. And, Apple shares rise in offhours trading after the company’s earnings top expectations. Luke Vargas hosts.
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By The Wall Street Journal4.2
652652 ratings
Plus: The FDA approves a new drug designed to cut the risk of addiction and overdoses related to opioids. And, Apple shares rise in offhours trading after the company’s earnings top expectations. Luke Vargas hosts.
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices

2,835 Listeners

1,720 Listeners

4,345 Listeners

404 Listeners

420 Listeners

1,657 Listeners

1,425 Listeners

1,038 Listeners

1,302 Listeners

6,089 Listeners

1,561 Listeners

213 Listeners

1,322 Listeners

586 Listeners

151 Listeners

85 Listeners

80 Listeners

142 Listeners